The
table below presents the number of securities that were excluded from the calculation of diluted net loss per share as the effect would
have been anti-dilutive:
SCHEDULE OF DILUTED NET LOSS PER SHARE ANTI-DILUTIVE
| | |
2026 | | |
2025 | |
| | |
Six
Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Share options | |
| 817,567 | | |
| 538,231 | |
| Ordinary Warrants | |
| 2,695,425 | | |
| - | |
| Underwriter Warrants | |
| 37,614 | | |
| - | |
| 2024 SAFE* | |
| - | | |
| 614,006 | |
| ●* | The
weighted average number of Ordinary Shares in connection with the 2024 SAFE for the six months
ended June 30, 2025 is based on the assumption the conversion of the 2024 SAFE into shares
will occur upon its maturity. |
|